Med Page Today
SEPTEMBER 5, 2024
(MedPage Today) -- Up to one in five prevalent dementia cases may be attributable to impaired vision, a cross-sectional analysis suggested. In a study of nearly 2,800 older Americans, the population attributable fraction (PAF) of prevalent dementia.
Dr. Smith's ECG Blog
SEPTEMBER 5, 2024
Written by Magnus Nossen - Edits by Grauer and Smith The patient in today’s case is a woman in her 70s with a previous medical history of HTN and hyperlipidemia. She presented to an outside hospital after several days of malaise and feeling unwell. At the time of admission, her vital signs were normal. Heart rate was in the 80s. She had a very elevated troponin T at 12,335 ng/L at the time of presentation. ( This is a value typical for a large subacute MI, n ormal value 48 hours after myocardial
Science Daily - Heart Disease
SEPTEMBER 5, 2024
Over-the-counter blood pressure measuring devices offer a simple, affordable way for people to track hypertension at home, but the standard arm-size ranges for these devices won't appropriately fit millions of U.S. consumers, according to a new study.
American Heart News - Heart News
SEPTEMBER 5, 2024
Research Highlights: A new study finds that up to 74% of participants with resistant or difficult-to-control high blood pressure, including those with chronic kidney disease, were able to improve control of their blood pressure within 12 months after.
HCPLive
SEPTEMBER 5, 2024
In an interview with HCPLive, Wadden discussed the findings of a post-hoc analysis, supporting how semaglutide is not linked to an increased suicidal ideation risk.
American Heart News - Heart News
SEPTEMBER 5, 2024
Research Highlights: In the first study, nearly 23% of young adults (ages 18-39 years) included in the NHANES 2017-2020 datasets had high blood pressure (130/80 mm Hg or greater). In addition, they were more likely to self-report being uninsured, food.
Science Daily - Stroke
SEPTEMBER 5, 2024
A study investigated the origin of ataxia in the brain of patients with stroke. A significant number of the stroke lesions in the patients were located outside the cerebellum.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
HCPLive
SEPTEMBER 5, 2024
The FDA has granted full approval to sparsentan (Filspari) for reducing proteinuria in adults with IgAN at risk of rapid disease progression based on PROTECT trial data.
American Heart News - Heart News
SEPTEMBER 5, 2024
Research Highlights: An analysis of at-home blood-pressure monitors estimates that the arm cuffs for 10 of the most popular potentially do not fit up to 18 million adults in the U.S. and nearly 12% of Black adults. To ensure accurate blood pressure.
Science Daily - Heart Disease
SEPTEMBER 5, 2024
A new study found that cardiovascular disease risk among Chinese American immigrants increases with length of residence and varies by location in the U.S.
HeartRhythm
SEPTEMBER 5, 2024
Sudden cardiac death (SCD) remains a pressing health issue, affecting hundreds of thousands each year globally. The heterogeneity among SCD victims, ranging from individuals with severe heart failure to seemingly healthy individuals, poses a significant challenge for effective risk assessment. Conventional risk stratification, which primarily relies on left ventricular ejection fraction, has resulted in only modest efficacy of implantable cardioverter-defibrillators (ICD) for SCD prevention.
NEJM Journal Watch - Cardiology
SEPTEMBER 5, 2024
During 30 years of follow-up, all three biomarkers significantly and independently predicted incidence of a major adverse cardiovascular event in women.
American College of Cardiology
SEPTEMBER 5, 2024
The following are key points to remember from the 2024 European Society of Cardiology (ESC) guidelines for the management of elevated blood pressure (BP) and hypertension.
HCPLive
SEPTEMBER 5, 2024
Host Veeral Sheth, MD is joined by John Sheets, PhD, the president, CEO, and co-founder of Pantheon Vision, an early research-stage organization working to develop bioengineered solutions to eliminate corneal blindness.
Journal of Cardiothoracic Surgery
SEPTEMBER 5, 2024
The purpose of this study was to investigate the diagnostic value of circ_0013958 in acute myocardial infarction (AMI) patients and its influence on the prognosis of AMI patients.
HCPLive
SEPTEMBER 5, 2024
The August 2024 month in review highlights our coverage of pipeline news, a cross-specialty feature about dialysis, and other recent renal news and research from the past few weeks.
Med Page Today
SEPTEMBER 5, 2024
(MedPage Today) -- Submaximal balloon angioplasty for symptomatic intracranial atherosclerotic stenosis (ICAS) improved outcomes over aggressive medical management alone, the BASIS trial from China showed. The incidence of the composite of any.
HCPLive
SEPTEMBER 5, 2024
A study found high error rates in racial and ethnic designations in pediatric health records across 3 Michigan hospitals, risking misinformed care strategies.
Learning + Leading
SEPTEMBER 5, 2024
In the dynamic landscape of healthcare, the imperative for a human-centered design has never been so high. Employers are continuously challenged with staffing shortages and burnout among healthcare workers. Concurrently, patients are increasingly vocal about their care experiences, articulating concerns such as long wait times, insufficient provider interaction, and a lack of personalized care.
HCPLive
SEPTEMBER 5, 2024
The rheumatology month in review emphasize's bimekizumab's efficacy in treating PsA and new risk factors and mitigators for developing gout or hyperuricemia.
Becker's Hospital Review - Cardiology
SEPTEMBER 5, 2024
A program combining remote monitoring and pharmacist support improved blood pressure in 74% of patients whose blood pressure was previously resistant to treatment.
HCPLive
SEPTEMBER 5, 2024
Vadadustat once-daily demonstrated noninferiority to darbepoetin alfa for the change in mean hemoglobin from baseline, while 3-times-weekly did not.
American College of Cardiology
SEPTEMBER 5, 2024
The ACC submitted formal comments to the Centers for Medicare and Medicaid Services (CMS) on Sept. 4, providing feedback and raising concerns on several issues of relevance to the cardiovascular community in the 2025 Hospital Outpatient Prospective Payment System (OPPS) proposed rule.
HCPLive
SEPTEMBER 5, 2024
Panelists discuss advanced treatment options for rheumatoid arthritis, focusing on the SELECT-COMPARE trial's head-to-head data of upadacitinib versus adalimumab, the use of upadacitinib in active RA refractory to biologics (SELECT-BEYOND trial), and the remission rates of upadacitinib compared to abatacept (SELECT-CHOICE trial).
Becker's Hospital Review - Cardiology
SEPTEMBER 5, 2024
New study reveals clonal hematopoiesis as a significant risk factor for heart disease.
HCPLive
SEPTEMBER 5, 2024
Panelists discuss how head-to-head clinical trial data shape their treatment decisions, the significance of consistent remission rates across different patient populations, and the frequency with which remission data influence their choices to switch therapies.
HeartRhythm
SEPTEMBER 5, 2024
Post-operative arrhythmias are most often transient and medically treated, but some patients may require electrophysiology study (EPS) and ablation.
HCPLive
SEPTEMBER 5, 2024
Deepak Bhatt, MD, MPH, MBA Bhatt a group of 4 high-impact studies from ESC Congress 2024: FINEARTS-HF, ABYSS, RESHAPE-HF2, and SHAM-PVI.
Journal of Cardiovascular Pharmacology
SEPTEMBER 5, 2024
Abstract: Extracorporeal membrane oxygenation (ECMO) is a mechanical support treatment modality utilized in patients with refractory cardiac and/or pulmonary failure. Bleeding and thrombotic complications associated with ECMO are inherent concerns that require careful management. Anticoagulation optimization may help mitigate these risks by providing more adequate therapeutic anticoagulation and lessen the bleed risk.
HCPLive
SEPTEMBER 5, 2024
The Delphi survey collected opinions from members of the European Alpha-1 Research Collaboration to guide the diagnosis, treatment, and management of severe AATD.
HeartRhythm
SEPTEMBER 5, 2024
In contrast to the intense interest in physiologic ventricular pacing over the last decade, the location of atrial pacing leads has received surprisingly little attention. The right atrial appendage, initially used because of the ability to obtain stable fixation of tined leads, remains the default option for almost all implants. Various locations in the right atrium, dual site right atrial, and biatrial pacing of the right and left atria have all been investigated, without showing a consistent
HCPLive
SEPTEMBER 5, 2024
These data were presented at the European Society of Contact Dermatitis congress, with findings drawn from the CHECK and RWEAL studies on chronic hand eczema.
HeartRhythm
SEPTEMBER 5, 2024
Lead-related venous stenosis and occlusion can complicate the insertion or replacement of transvenous leads in patients with cardiac implantable electronic devices (CIED). A possible solution is to tunnel the lead from the contralateral vasculature to the ipsilateral generator. Procedural complications and long term outcomes remain unclear with this technique.
The American Journal of Cardiology
SEPTEMBER 5, 2024
Publication date: Available online 4 September 2024 Source: The American Journal of Cardiology Author(s): Kitae Kim, Ryosuke Murai, Taiji Okada, Toshiaki Toyota, Yasuhiro Sasaki, Tomohiko Taniguchi, Natsuhiko Ehara, Atsushi Kobori, Makoto Kinoshita, Yutaka Furukawa
HCPLive
SEPTEMBER 5, 2024
Participants in a study in China also experienced comparable safety and immunogenicity.
The American Journal of Cardiology
SEPTEMBER 5, 2024
Publication date: Available online 4 September 2024 Source: The American Journal of Cardiology Author(s): Tijs Bringmans, Alice Benedetti, Carlo Zivelonghi, Maarten Vanhaverbeke, Frédéric Daniel Mathieu, Pieter-Jan Palmers, Patrick Coussement, Kenneth De Wilder, Bert Everaert, Mathieu Coeman, Fabian Demeure, Maarten Kersemans, Carlos Collet Bortone, Peter Kayaert, Carlos Van Mieghem, Vincent Frans Maria Segers
NEJM Journal Watch - Cardiology
SEPTEMBER 5, 2024
New randomized trial findings suggest limiting this strategy to patients with the most severe disease.
Expert insights. Personalized for you.
131 
Let's personalize your content